DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.59

EPS Forecast

$19.01

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
NBIXNeurocrine Biosciences IncTECHBio-techne CorpHALOHalozyme Therapeutics IncCRSPCrispr Therapeutics AgIOVAIovance Biotherapeutics IncMRNAModerna IncNVAXNovavax IncREPLReplimune Group IncRGENRepligen Corp